Investor Update

Basel, 14 June 2013

Anti-Cancer Agent, Herceptin® Obtained Approval for Dosage and Administration for Postoperative Adjuvant Chemotherapy in Breast Cancer in Japan

Dear Investor,

Please find attached a press release by Chugai.

Do not hesitate to contact us for any further questions.